|
"dai chia yen"的相關文件
顯示項目 16-25 / 64 (共7頁)
<< < 1 2 3 4 5 6 7 > >>
每頁顯示[10|25|50]項目
| 國立交通大學 |
2020-10-05T02:01:06Z |
Severe acute exacerbation of HCV infection in cancer patients who undergo chemotherapy: Some issues
|
Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2020-10-05T01:59:45Z |
Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradication
|
Huang, Chung-Feng; Dai, Chia-Yen; Yeh, Ming-Lun; Huang, Ching-, I; Lee, Hsiang-Chun; Lai, Wen-Ter; Liang, Po-Cheng; Lin, Yi-Hung; Hsieh, Ming-Yen; Hou, Nai-Jen; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2020-07-01T05:21:16Z |
Risk of hepatitis C virus infection in injecting and noninjecting drug users receiving opioid substitution therapy
|
Wang, Chih-Wen; Chuang, Hung-Yi; Chiang, Hung-Che; Huang, Po-Chin; Yu, Ming-Lung; Dai, Chia-Yen |
| 國立交通大學 |
2020-07-01 |
Clusters of Circulating let-7 Family Tumor Suppressors Are Associated with Clinical Characteristics of Chronic Hepatitis C
|
Yu, Ming-Lung; Dai, Chia-Yen; Chuang, Wan-Long; Tsai, Yi-Shan; Yeh, Ming-Lun; Tsai, Pei-Chien; Huang, Ching-, I; Huang, Chung-Feng; Hsieh, Meng-Hsuan; Liu, Ta-Wei; Lin, Yi-Hung; Liang, Po-Cheng; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu |
| 國立交通大學 |
2020-05-05T00:02:21Z |
Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos(t)ides analogues therapy
|
Yu, Ming-Lung; Dai, Chia-Yen; Huang, Chung-Feng; Chuang, Wan-Long; Huang, Jee-Fu; Chen, Shinn-Cherng; Lin, Zu-Yau; Huang, Ching-, I; Yeh, Ming-Lun; Wang, Shu-Chi; Lin, Yi-Hung; Liang, Po-Cheng; Hsieh, Meng-Hsuan; Ko, Yu-Min; Tsai, Yi-Shan; Chen, Kuan-Yu; Lin, Ching-Chih; Tsai, Pei-Chien; Liu, Ta-Wei; Hsu, Po-Yao; Hsu, Cheng-Ting; Jang, Tyng-Yuan; Wei, Yu-Ju |
| 國立交通大學 |
2020-02-02T23:54:42Z |
Higher NAFLD fibrosis score is associated with impaired eGFR
|
Hsieh, Meng-Hsuan; Wu, Kuan-Ta; Chen, Yi-Yu; Yang, Jeng-Fu; Lin, Wen-Yi; Chang, Ning-Chia; Lin, Chia-Yi; Huang, Chao-Kuan; Wang, Chao-Ling; Chuang, Hung-Yi; Lin, Shu-Ching; Hsu, Yu-Kuei; Tsai, Yi-Shan; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen |
| 國立交通大學 |
2019-12-13T01:12:24Z |
Pharmacokinetics and pharmacodynamics of pegylated interferon for the treatment of hepatitis B
|
Yeh, Ming-Lun; Huang, Jee-Fu; Dai, Chia-Yen; Yu, Ming-Lung; Chuang, Wan-Long |
| 國立交通大學 |
2019-12-13T01:09:57Z |
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions
|
Huang, Chung-Feng; Hung, Chao-Hung; Cheng, Pin-Nan; Bair, Ming-Jong; Huang, Yi-Hsiang; Kao, Jia-Horng; Hsu, Shih-Jer; Lee, Pei-Lun; Chen, Jyh-Jou; Chien, Rong-Nan; Peng, Cheng-Yuan; Lin, Chun-Yen; Hsieh, Tsai-Yuan; Cheng, Chun-Han; Dai, Chia-Yen; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2019-12-13T01:09:55Z |
Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents
|
Jang, Tyng-Yuan; Huang, Ching-, I; Yeh, Ming-Lun; Liang, Po-Cheng; Tsai, Pei-Chien; Lin, Yi-Hung; Hsieh, Ming-Yen; Hou, Nai-Jen; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Huang, Chung-Feng; Chuang, Wan-Long; Yu, Ming-Lung |
| 國立交通大學 |
2019-12-13T01:09:55Z |
Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir
|
Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-, I; Liang, Po-Cheng; Lin, Yi-Hun; Hsieh, Ming-Yen; Chen, Kuan-Yu; Ko, Yu-Min; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung |
顯示項目 16-25 / 64 (共7頁)
<< < 1 2 3 4 5 6 7 > >>
每頁顯示[10|25|50]項目
|
